Medpace (MEDP) director receives 1,110 stock options at $415.27 strike price
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Medpace Holdings, Inc. director Cornelius P. McCarthy III received a grant of stock options covering 1,110 shares of common stock at an exercise price of $415.2700 per share. These options expire on May 15, 2033 and are a compensation-related award, not an open-market purchase.
According to the footnote, the option vests on the earlier of the day immediately preceding the first annual shareholder meeting after the grant date or the first anniversary of the grant, subject to his continued service on the board. Following the reported transactions, he holds 10,324 shares of common stock directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
McCarthy Cornelius P. III
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 1,110 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 1,110 shares (Direct, null);
Common Stock — 10,324 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Option grant size: 1,110 options
Exercise price: $415.2700 per share
Option expiration: May 15, 2033
+1 more
4 metrics
Option grant size
1,110 options
Stock Option (Right to Buy) granted to director on May 15, 2026
Exercise price
$415.2700 per share
Conversion or exercise price for 1,110 stock options
Option expiration
May 15, 2033
Expiration date for the granted stock options
Shares owned after
10,324 shares
Total Medpace common shares directly held after transactions
Key Terms
Stock Option (Right to Buy), exercise price, vests, board of directors
4 terms
Stock Option (Right to Buy) financial
"security_title": "Stock Option (Right to Buy)""
exercise price financial
"conversion_or_exercise_price": "415.2700""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vests financial
"The option vests on the earlier of (i) the day immediately preceding"
board of directors financial
"subject to continued service on the board of directors of the Issuer"
The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.
FAQ
What did Medpace (MEDP) director Cornelius P. McCarthy III receive in this Form 4?
Medpace director Cornelius P. McCarthy III received a grant of stock options for 1,110 shares of common stock. The options are a compensation-related award at an exercise price of $415.2700 per share, not an open-market share purchase or sale.
What is the exercise price and expiration date of the new Medpace (MEDP) stock options?
The granted stock options have an exercise price of $415.2700 per share and expire on May 15, 2033. This defines the price at which the director can buy Medpace common shares before the stated expiration date, subject to vesting conditions.
How and when do the Medpace (MEDP) options granted to the director vest?
The options vest on the earlier of two dates: the day immediately before the first Medpace annual meeting after the grant, or the first anniversary of the grant. Vesting is conditioned on the director’s continued service on the board through the vesting date.